haku: @indexterm patents / yhteensä: 284
viitteet: 64-73 / 284
« edellinen sivu | seuraava sivu »
 otsikkovuositekijä
64.
Intellectual property and the pharmaceutical industry: a moral crossroads between health and property
Journal of Business Ethics
2004 : DEC II, VOL 55:3, p. 295-308
 2004 Gewertz, N. M.
Amado, R.
65.
Imitation, patent protection, and welfare
Oxford Economic Papers
2004 : OCT, VOL. 56:4, p. 715-733
 2004 Mukherjee, A.
Pennings, E.
66.
Accounting for the recent surge in U.S. patenting: changes in R&D expenditures, patent yields, and the high tech sector
Economics of innovation and new technology
2004 : SEP, VOL. 13:6, p. 543-558
 2004 Kim, J.
Marschke, G.
67.
An R&D Roundtable
Economics of innovation and new technology
2004 : JUN, VOL 13:4, p. 349-363
 2004 Kortum, S.S.
68.
Patentability, industry structure, and innovation
Journal of Industrial Economics
2004 : SEP, VOL. 52:3, p. 401-425
 2004 Hunt, R.M.
69.
Little patents and big secrets: managing intellectual property
RAND Journal of Economics
2004 : SPRING, VOL. 35:1, p. 1-22
 2004 Anton, J.J.
Yao, D.A.
70.
Curing strategic myopia: drug pricing & health care
Human Systems Management
2004 : VOL. 23:3, p. 161-168
 2004 Singer, A.E.
71.
Patterns of technological specialisation in Latin American and East Asian countries: an analysis of patents and trade flows
Economics of innovation and new technology
2004 : OCT, VOL. 13:7, p. 615-653
 2004 Huang, H-T.
Miozzo, M.
72.
Patents as surrogates for inimitable and non-sustitutable resources
Journal of Management
2004 : VOL. 30:4, p. 529-544
 2004 Markman, G.D.
Espina, M.I.
Phan, P.H.
73.
Patent quality and research productivity: Measuring innovation with multiple indicators
Economic Journal
2004 : APR, VOL. 114:495, p. 441-465
 2004 Lanjouw, J.O.
Schankerman, M.
« edellinen sivu | seuraava sivu »
SCIMA